As of 2025-12-16, the Intrinsic Value of Forte Biosciences Inc (FBRX) is -16.94 USD. This FBRX valuation is based on the model Peter Lynch Fair Value. With the current market price of 21.96 USD, the upside of Forte Biosciences Inc is -177.14%.
Based on its market price of 21.96 USD and our intrinsic valuation, Forte Biosciences Inc (FBRX) is overvalued by 177.14%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -16.94 - -16.94 | -16.94 | -177.14% |
| P/E | (47.43) - (63.83) | (58.95) | -368.4% |
| DDM - Stable | (20.68) - (71.54) | (46.11) | -310.0% |
| DDM - Multi | (14.72) - (41.75) | (22.01) | -200.2% |
| Market Cap (mil) | 275.16 |
| Beta | 1.69 |
| Outstanding shares (mil) | 12.53 |
| Enterprise Value (mil) | 169.01 |
| Market risk premium | 4.60% |
| Cost of Equity | 11.87% |
| Cost of Debt | 5.00% |
| WACC | 7.77% |